 | | Prognostische waarde van (micro)albuminurie voor cardiovasculaire events |
|  | | The PREVEND Study Acronym for: Prevention of REnal and Vascular ENd-stage Disease Study Since 1997 Groningen, The Netherlands www.PREVEND.org |
|
 | | Pivotal questions Kan de risico marker makkelijk, goedkoop en niet belastend worden gemeten? Voorspelt de risico marker CV uitkomst? Voorspelt de risicomarker CV uitkomst onafhankelijke van andere, “gevestigde” risicofactoren / -markers? Leidt interventie gebaseerd op de risicomarker tot risico reductie? Voegt bepaling van de risicomarker toe aan huidige CV risico profilering? |
|  | | Prevalence of micro-albuminuria - The general non-diabetic population - |
|
 | | Albuminuria as predictor of CV mortality - The general population - |
|  | | MA predicts CV events in the general population - The Danish Monica Study - |
|
 | | Albuminuria as determinant of CV events in hypertension with LVH |
|  | | Interplay between albuminuria and renal function in predicting outcome |
|
 | | Albuminuria as predictor of ESRD - 8 years of follow-up - |
|  | | Community based screening for MA - A predictor for eGFR deterioration? - |
|
 | | Interplay between albuminuria and renal function in predicting outcome |
|  | | “Isolated microalbuminuria” Baseline characteristics |
|
 | | “Isolated microalbuminuria” The effect of ACE inhibition |
|  | | RAS Intervention protects the heart - Particularly in those with poor renal function - PEACE Trial |
|
 | | Efficacy screen / treat program preventing ESRD - Yield depends on baseline eGFR and albuminuria - |
|  | | RAS Intervention protects the heart - Particularly in those with micro-albuminuria - |
|
 | | Does measuring albuminuria add to present CV risk profiling scores? |
|  | | Does measuring albuminuria add to present CV risk profiling scores? |
|
 | | Does measuring albuminuria add to present CV risk profiling scores? |
|  | | Title |
|
 | | K/DOQI staging of chronic kidney disease - To facilitate renal AND CV risk stratification - |
|  | | LTA Nierfalen (2009, concept) |
|
 | | LTA Nierfalen (2009, concept) |
|  | | KDIGO classification of CKD (2009, concept) |
|
 | | KDIGO classification of CKD (2009, concept) |
|  | | Predictive value of albuminuria Does it matter which albuminuria measure is used? |
|
 | | “Isolated microalbuminuria” Cost-effectiveness of screening and ACEi |
|  | | LTA Nierfalen (2009, concept) |
|
 | | Renoprotective treatment should be started early |
|  | | The course of renal function Lessons to be learnt from the diabetic population? |
|
 | | The value of mass screening for albuminuria - Study selection procedure - |
|  | | Albuminuria only result of DM / HT? High incidence of de novo CV risk factors |
|
 | | Subjects with hypercholesterolemia and prior CVD - Proteinuria and eGFR versus mortality and CVD - |
|  | | Effects of ACEi - The “healthy” with micro-albuminuria - |
|
Deel deze pagina met collega's en vrienden: